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Summary 
The normal migration route of B cells into follicular areas of spleen and lymph nodes is altered 
in the case of autoreactive cells that have bound self-antigen. To begin characterizing the molec- 
ular requirements for B cell migration into follicles, cells were treated with pertussis toxin (FTX), 
an inhibitor of signaling by many G protein-coupled chemokine receptors. Lymphocyte accumu- 
lation in the spleen is not inhibited by PTX and, therefore, the distribution of transferred cells 
was examined in this tissue.  In contrast to untreated cells that localized predominantly in follic- 
ular areas within white pulp cords, PTX-treated B cells failed to enter white pulp areas altogether 
and accumulated in the splenic red pulp. T cells were also excluded from white pulp cords and 
in the case of both cell types, the adenosine diphosphate-ribosylating subunit of the toxin was 
required to block white pulp entry. These findings implicate a G protein-coupled receptor in 
lymphocyte migration into splenic white pulp cords. Exclusion of PTX-treated cells from all 
organized areas of secondary lymphoid tissues raises the possibility that the association observed 
between PTX treatment and predisposition to autoimmune disease results from inhibition of 
tolerance mechanisms that normally operate within secondary lymphoid tissues. 
T 
he  spleen  is  a  major  secondary lymphoid tissue  im- 
portant in host protection against many bacterial and 
parasitic infections (1). Most of the lymphocytes present within 
the spleen occupy well-defined regions, termed white pulp 
cords, that sheathe arterioles. Within the white pulp, the major 
lymphocyte subsets are organized into discrete zones including 
inner T  cell areas (periarteriolar lymphoid sheaths [PALS]) 
and outer B cell areas or follicles  (2,  3).  Cords of large di- 
ameter are surrounded by a highly vascularized region, the 
marginal zone, which consists of loosely associated  B cells, 
macrophages and reticular cells, and forms the border between 
the white pulp and the red pulp. Arterioles terminate both 
in the marginal zone and red pulp (3-5),  and erythrocytes 
and neutrophils accumulate only in these zones, whereas many 
lymphocytes migrate into the white pulp cords by unknown 
mechanisms. Within the cords, B and T  lymphocytes ini- 
tially move along a common pathway before segregating into 
their respective areas  (6,  7). 
Migration of B and T cells into the white pulp is thought 
to be essential for immune responses to occur within the spleen 
because it is in this region that antigen-specific interactions 
between lymphocytes and accessory cells take place (1-3, 8). 
In recent studies, we have shown that the white pulp cords 
of the spleen are also sites where the purging of self-reactive 
B cells can occur. B cells with high affinity for a soluble self- 
antigen enter the white pulp but are excluded from contin- 
uing their normal migration route into follicles, and instead 
accumulate in the outer T cell area before dying within 2 d (9). 
In considering molecules that may influence B cell migra- 
tion in lymphoid tissues,  some members of the chemokine 
family of cytokines are active in promoting directional move- 
ment  of lymphocytes  (10-13).  Chemokine  receptors  are 
members of the seven-transmembrane, G  protein-coupled 
receptor family. Many of the known receptors signal through 
G proteins sensitive  to pertussis toxin,  a multisubunit en- 
zyme that ADP ribosylates and inactivates those Gc~ pro- 
teins that have a cysteine residue four amino acids from the 
carboxy terminus (13, 14). Lymphocytes treated with PTX 
fail to enter lymph nodes and Peyer's patches, and are unable 
to accumulate at sites of inflammation in tissues (15-20). Ac- 
cumulation of cells in the spleen, however, is not reduced 
by PTX treatment (15,  17-19), allowing the potential role 
of G protein-coupled receptors in B cell migration into fol- 
licles  to be studied. 
Materials and Methods 
Pre~ration and Treatment of Lymphocytes.  Splenocytes  from anti- 
HEL Ig transgenic (MD4 line [21]) or LyS'-congenic C57BL/6 
mice were isolated as previously described (21) and resuspended in 
RPMI, 2% calf serum, 10 raM Hepes, 2 mM glutamine, 100 mg/ml 
streptomycin, and 100 U/m1 penicillin. After washing, the cells 
were incubated in six-weU  plates (Costar Corp., Cambridge, MA) 
at 3 x 107 cells per ml with 100 ng/ml pertussis toxin, 100 ng/ml 
B oligomer (both from List Biological  Laboratories, Campbell, CA) 
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5% CO2. 5x107 washed cells were injected into the tail vein of 
6-12-wk-old C57BL/6 mice that were sex-matched  with the donors. 
Flow Cytometry.  Three color FACS  |  analysis  (Becton  Dickinson 
& Co., Mountain View, CA) was performed on a FACScan  * with 
FACS desk software (Beckman Center Shared FACS Facility,  Stan- 
ford, CA). Surface marker staining was as previously described (9, 
21, 22) using the mAbs B220, RA3-6B2-PE (Cahag Laboratories, 
San Francisco, CA); IgD  a, AMS9.1-fluorescein  (FITC); Ly5h A20- 
1.7-FITC; Thyl.2-biotin (Caltag) followed  by streptavidin-cychrome 
(PharMingen, San Diego, CA). Hen egg lysozyme (HEL) binding 
was measured by incubating the cells with 200 ng/ml HEL (Sigma 
Immunochemicals, St. Louis, MO) followed by anti-HEL mAb 
HyHEL9-biotin  and streptavidin-cychrome. 
Immunohistochemistry  and Immunofluorescence.  6- or 7-#m cryo- 
stat sections were fixed  and stained for immunohistochemistry as 
previously described (9, 22). HEL was detected with HyHEb9 
biotin, and Ly5  a was detected with AS20-biotin, in each case fol- 
lowed by avidin-conjugated  alkaline  phosphatase (Sigma). The mar- 
ginal zone was outlined with MOMA-1 (kindly provided by G. 
Kraal, Free University of Amsterdam, The Netherlands) an mAb 
specific for  metallophilic  macrophages  (3), followed by  goat 
anti-rat-conjugated horseradish  peroxidase  (Southern Biotechnology 
Associates, Birmingham, AL). For fluorescence  microscopy,  cryostat 
sections were air dried and stained with HEL/HyHEL9-biotin/ 
streptavidin-PE (Cahag); MOMA-1/goat anti-rat IgG-FITC (Cal- 
tag); anti-CD79B rabbit antiserum/Donkey anti-rabbit IgG-FITC 
(Jackson ImmunoResearch Laboratories, West Grove, PA). The 
rabbit  anti-CD79/~ serum  was  raised against  a  glutathione-S- 
transferase fusion protein incorporating the cytoplasmic tail (Asp 
181-Glu228) of CD79B. Two-color  fluorescence  was visualized  and 
photographed through a dual filter system: excitation 480-500 nm 
and emission 517-532 nm (FITC) and excitation 545-578 nm and 
emission 585-620 nm (PE) (Chroma, Brattleboro, VT). Cells were 
enumerated in immunohistochemically  stained sections using a grid 
in one eyepiece  containing 56 x 56-#m squares. Cells falling  within 
a minimum of 200 squares of red pulp and 200 squares of white 
pulp were counted per section, and the number of cells counted 
was divided by the number of squares to give a value per unit area. 
Results 
To determine whether or not B cell migration into follicular 
areas within the spleen  was altered by PTX,  Ig-transgenic 
mice expressing Ig specific for HEL were used as a source 
of B cells with a uniform high level of antigen receptor ex- 
pression and a resting phenotype (9,  21). Furthermore, the 
high affinity HEL-binding Ig expressed  on the transgenic B 
cells allowed them to be tracked specifically without an in 
vitro labeling step (9). Splenocytes from Ig-transgenic donor 
animals were incubated with or without PTX in vitro for 
2 h before injection into the tail vein of nontransgenic, syn- 
geneic recipients.  The sham-treated (control) B cells were de- 
tected in the spleen and lymph nodes within 6 h of transfer 
and were present in similar numbers 19 h after transfer (Fig. 
1). By contrast, PTX-treated B cells failed to accumulate in 
cervical and mesenteric lymph nodes 6 and 19 h after transfer 
(Fig.  1), whereas their frequency in the spleen was similar 
to controls. The frequency of PTX-treated B cells in the blood 
19 h  after transfer was fourfold greater than that of sham- 
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Figure  1.  Pertussis  toxin treatment  does not inhibit B cell accumula- 
tion in the spleen. (.4) Flow cytometry  of spleen cells from mice 19 h 
after intravenous  injection  of sham-treated (control) or PTX-treated Ig- 
transgenic  cells, or a control  that did not receive  transferred  cells (no cells), 
stained to detect HEL binding and IgD~-positive  cells. The percentage  of 
spleen cells in the HEL-positive, IgD'-positive  window are shown. (/3) 
Frequency of transferred  cells detected  in spleen, lymph  nodes (a pool of 
mesenteric and cervical), and blood 6 and 19 h after transfer, determined 
by flow cytometry  as in A. Values from individual mice are shown by 
dots and means are shown  by columns. 
treated cells. This lymphocytosis effect, first observed in Bor- 
detdla pertussis-infected patients (reviewed  in reference 23), 
most likely reflects the reduced exit of B cells from blood 
into lymph nodes, Peyer's patches,  and gut (17, 20). 
To examine the location of transferred B cells within recip- 
ient spleens, sections were stained to detect HEL-binding B 
cells and their distribution was compared with all B cells re- 
vealed by a polyclonal antibody specific for CD79/~ (B29/Ig~) 
(Fig. 2 A-C). Sham-treated HEL-binding B cells in control 
recipients were distributed evenly among the recipients' en- 
dogenous B cells in the follicular areas of the spleen  (Fig. 
2 B) and lymph nodes (data not shown). In the spleen, small 
numbers of transferred cells were also detected in the mar- 
ginal zone and red pulp as previously observed (24). By con- 
trast, PTX-treated, HEL-binding B cells were not only ex- 
cluded from lymph nodes, but they also could not be detected 
in follicles in the splenic white pulp cords (Fig. 2 C). Unlike 
autoreactive B cells that accumulate in the outer T cell zone 
(9), FTX-treated B cells appeared to be completely excluded 
from the white pulp. This was confirmed by double staining 
to detect metallophiUic macrophages lining the marginal zone 
and HEL-binding cells  (Fig 2 D-F).  The  marginal zone 
staining outlined the white pulp cords and few or no PTX- 
treated cells were detected within the cords,  whereas large 
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cytes fail  to enter splenic white pulp cords. 
(A-F) Effect  of PTX on migration  of HEL- 
specific  B cells. Spleen  sections  from  a mouse 
that did not receive  transferred  cells (.4 and 
D), or from  mice  that received  sham-treated 
(B and E) or PTX-treated (C and F) HEL- 
specific Ig transgenic  cells 19 h earlier, were 
stained for CD79B (A-C, green) and HEIr 
binding (red) or (D-E) the marginal zone 
macrophage marker MOMA-1 (green) and 
HEL binding  (red). Note  that small  numbers 
of autofluorescent  (orange) cells are present 
in the white  pulp in the absence of any cells 
being transferred  (.4 and D), and that they 
are also  evident  in (C and F). These  cells  did 
not have  the morphology  of  lymphocytes  and 
are readily  distinguished  from HEI~binding 
B cells, x32. (G-I) Effect  of  PTX on migra- 
tion of LyS'-marked lymphocytes. Spleen 
sections from  mice  that receiv~ sham- (G), 
B oligomer- (H), or PTX-treated (I) cells 
14 h earlier were stained  by immunohisto- 
chemistry for MOMA-1 (brown) and Ly5  a 
(red).  xSO. 
numbers of cells were visible in the red pulp (Fig. 2 F). Similar 
distributions of HEL-binding cells were observed  in spleens 
taken from recipients 6 or 19 h after cell transfer (data not 
shown). 
To exclude the possibility that the PTX-sensitive step of 
B cell entry into the splenic white pulp was restricted to trans- 
genie B cells, the fate of nontransgenic B cells and of T cells 
was  followed  using  cells  from  LyS~-congenic  C57BL/6 
donors. In recipients  of sham-treated cells, Ly5~-positive cells 
detected by immunohistochemical staining of spleen cryosec- 
tions were concentrated within white pulp cords (Fig. 2 G), 
and  the  presence  of both  transferred B  and  T  cells  was 
confirmed by double staining with antibodies specific for ei- 
ther B220 or CD4 and CD8 versus Ly5  ~ (data not shown). 
By contrast, as observed for Ig-transgenic B cells, pretreat- 
merit with  PTX  completely blocked  appearance  of Ly5  '- 
positive lymphocytes in splenic white pulp cords (Fig. 2 I). 
Failure to detect PTX-treated B or T  cells in the white 
pulp did not reflect surface marker downregulation because 
sham-treated and PTX-treated B and T cells in the recipient 
spleens expressed  equivalent levels Ly5  ', as assessed by flow 
cytometry (Fig.  3 A).  Furthermore, the number of Ly5  '- 
positive cells detectable by immunohistochemistry per unit 
area of red pulp was elevated 2.5-fold in the spleen of PTX- 
treated groups (Fig. 3 C). Since the red pulp volume/white 
pulp volume ratio is ~o2:1 (25-27) and, conversely, the ratio 
of sham-treated lymphocytes in these zones is 1:2.6 (Fig.  3 
C), a 2.5-fold increase in the number of PTX-treated cells 
in the red pulp, combined with a complete absence of cells 
in the white pulp, leads to the prediction that similar numbers 
of cells should be present in the spleen as a whole. This predic- 
tion was borne out by the flow cytometry results where the 
frequencies  of sham-treated and PTX-treated LyS~-positive 
cells in the spleen  were equivalent (Fig.  3 B). 
PTX is composed of a membrane-permeabilizing complex, 
the B oligomer, and an ADP-ribosylating G protein-inacti- 
vating subunit (14). The B oligomer acts as a mitogen for 
B and T  cells under some in vitro culture conditions (30) 
and could therefore influence lymphocyte  migratory behavior 
in vivo.  To exclude this possibility cells were treated with 
purified B oligomer and tested in the same manner as cells 
incubated with the intact holoenzyme. B oligomer treatment 
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did not significantly reduce lymphocyte entry into lymph 
nodes or into the white pulp cords of the spleen (Fig.  2 H 
and 3), confirming the need for the G protein inactivating 
subunit to block migration into the splenic white pulp. 
Discussion 
Our results demonstrate that lymphocyte  entry into the splenic 
white pulp is a PTX-sensitive step.  This finding implicates 
G protein-coupled receptors in this process,  and it reveals 
similarities between migration into splenic white pulp and 
into lymph nodes. Lymphocyte entry into lymph nodes and 
Peyer's patches involves transient rolling along the endothelial 
surface followed by switching to a strongly adherent state 
in which the cells bind and begin migrating between the en- 
dothelial cells. The transition from rolling to sticking involves 
signaling through a PTX-sensitive G  protein (20). 
Lymphocyte entry into the splenic parenchyma has been 
less well characterized than entry into lymph nodes. Blood 
flow through the mouse spleen is mostly of the open type 
i  i  since the arteri~  d~ n~  c~  directly tO venules but 
terminate within the marginal zone or in the red pulp (4, 
5). Open circulation is not observed in lymph nodes and this 
difference may account for the insensitivity to PTX treat- 
ment of lymphocyte accumulation in the spleen as a whole 
because entry into the red pulp probably does not require 
active migration across  an endothelial layer. The increased 
frequency of PTX-treated lymphocytes in the red pulp is ex- 
B  T  peered given both the failure of cells to move into the white 
blood  pulp and their elevated  frequency in the blood itself. 
The route of lymphocyte traffic into splenic white pulp 
cords is unclear. From the observations of several early studies 
showing an initial accumulation of transferred cells in the 
[] ~ont~ol  marginal zone with a later appearance in the PALS, it was 
[] B-oligomer  argued that cells migrated from the marginal zone directly 
[] PTX  into the PALS (6, 25, 29). Although this route may operate, 
[]  none  recent studies support a more prominent role for lympho- 
cyte trafficking into the white pulp from distal PALS present 
around arterioles that terminate in the red pulp.  Lympho- 
cytes were suggested to gain access to the distal PALS by ac- 
tively crossing the endothelium immediately upstream of the 
"  arteriole terminus (30, 31). Since most forms of lymphocyte 
migration across endothelium are IrFX sensitive,  the failure 
of PTX-treated lymphocytes to enter white pulp cords sup- 
ports the hypothesis that the major site of entry into the white 
pulp is by first crossing endothelium in the distal PALS. It 
is equally possible,  however, that lymphocyte migration into 
white pulp cords from the marginal zone or after release from 
terminal arterioles into the red pulp is along a chemotactic 
gradient. By studying the distribution of PTX-treated lym- 
phocytes in the spleen at early time points after transfer,  it 
should be possible to determine whether entry into marginal 
zones, distal PALS, or both are reduced and, therefore, to 
define the main routes of lymphocyte trafficking into the white 
pulp. 
Pertussis toxin promotes the development of autoimmune 
disease in animal models such as experimental allergic en- 
cephalomyelitis (EAE) and experimental allergic uveoretinitis 
(EAU) (reviewed in reference 25). Although the basis for this 
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Figure 3.  B and T lymphocyte  entry into lymph nodes but not spleen 
is equally  inhibited  by intact PTX but not by B oligomer.  (A) Flow  cytom- 
etry of recipient spleens 14 h after transfer of control, B oligomer-, or 
PTX-treated  LySa-positive  splenocytes,  stained for B220 or Thyl.2 to de- 
tect B and T cells, respectively, and Ly5' to detect transferred cells. 
Numbers represent  percentage  of  cells  present  within the indicated  window. 
(B) The percentage  of transferred  B (/3220  +) and T (Thyl.2  +) cells de- 
tected  in spleen,  lymph  nodes  (a pool of  mesenteric  and cervical),  and blood 
14 h after  transfer,  determined  by flow  cytometry  as in A. Means  and stan- 
dard deviations are shown for three to six mice  per group. (C) Quantita- 
tion of Ly5*-positive  cells per unit area  of white pulp and red pulp in the 
spleen of recipients that received  control, B oligomer-, or PTX-treated 
cells, or no cells (none).  Cells  were  enumerated  as in Materials  and Methods. 
Values from individual  mice  are shown by dots and means are shown  by 
columns. 
584 effect of PTX on EAE and EAU is unknown, it is thought 
that its capacity to increase vascular permeability may be an 
explanation (23, 32). The findings described here raise an al- 
ternative possibility, namely that PTX treatment may im- 
pede peripheral B and T cell tolerance mechanisms normally 
operating within lymph nodes or white pulp cords of the 
spleen.  Elimination of autoreactive B cells by follicular ex- 
clusion (9), for example, may require the B cells to enter white 
pulp cords or lymph nodes and be held up in the T ceU zone. 
Similarly, B cell presentation of autoantigens to T cells, which 
may be tolerogenic for the latter cells in certain circumstances, 
would be inefficient without concentration of B and T cells 
in white pulp cords and T  zones. Interference with periph- 
eral tolerance mechanisms in combination with increased vas- 
cuhr permeability in some peripheral sites may allow autoreac- 
tive T or B cells to become activated and enter nonlymphoid 
tissues. 
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